| Expression pattern: |
DN |
| Associated gene: |
ATG4B, RNF5, ELAVL1/HuR |
| Associated microRNA: |
- |
| Biological function: |
CircSPECC1 suppresses ATG4B-mediated autophagy, enhances anoikis, inhibits anoikis resistance, and reduces gastric cancer metastasis. |
| Molecular mechanism: |
CircSPECC1 physically interacts with ATG4B and RNF5 to form a trimer complex, promotes ATG4B liquid-liquid phase separation and ubiquitination/degradation, thereby suppressing autophagy and enhancing anoikis. m6A-dependent ELAVL1/HuR recognition suppresses circSPECC1, increasing ATG4B and anoikis resistance; lopinavir blocks ELAVL1-circSPECC1 interaction and restores circSPECC1. |
| Biological pathway or process: |
autophagy (inhibits); apoptosis (promotes); metastasis (inhibits); ubiquitination (promotes); m6A modification (other); other pathway/process (promotes) |
| Detected method: |
Q
H
|
| Validation methods: |
RT-qPCR; ISH (In Situ Hybridization); FISH / smFISH; IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; MeRIP / MeRIP-seq; Transfection; Annexin V/PI Flow Cytometry; CCK8; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; Survival Analysis; ROC Analysis; Bioinformatics Analysis; Cohort Study |
| Clinical significance: |
CircSPECC1 is decreased in gastric cancer tissues, negatively correlated with TNM stage, lymphatic metastasis, distant metastasis and ATG4B expression; low circSPECC1 expression is associated with poor survival, and conjoint analysis with ATG4B can predict prognosis. |
| Description: |
CircSPECC1 is downregulated in gastric cancer and acts as an anti-metastatic circRNA by binding ATG4B and RNF5, promoting ATG4B phase separation, ubiquitination and degradation. Its loss increases ATG4B-mediated autophagy and anoikis resistance, while lopinavir restores circSPECC1 by blocking ELAVL1/HuR-mediated repression, thereby enhancing anoikis and reducing metastasis. Low circSPECC1 expression is associated with advanced disease features and poor survival. |
| Confidence score: |
0.837 |